Acid reflux and GERD affect 1 in 5 adults across Africa—yet millions go untreated, unaware of the long-term health risks.
That changes now.
We proudly launched Shalcer in Nigeria—a powerful proton pump inhibitor (PPI) designed to deliver fast, effective, and lasting relief from GERD and other gastric disorders.
The launch marks more than the arrival of a treatment—it signals a bold step forward in our mission to empower digestive health and improve quality of life across the continent.
Shalcer is backed by science which will ensure advanced gastro care accessible, affordable, and more impactful—for everyone who needs it.
The gut revolution has begun—and we are leading the way.
